Dr. Daniel A. Leung, M.D.
Interventional Radiology (Vascular & Interventional Radiology Physician)
- Medicare participating
At a glance
- Years since graduation
- 33
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 508
Licensed in Delaware since 2008, according to the Delaware Division of Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Vascular & Interventional Radiology Physician primary
DE license C1-0008883 (first issued 2008; active) · VA license 0101037410 -
Diagnostic Radiology Physician
DE license C1-0008883 (first issued 2008; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Christiana Hospital Newark, DE
- Union Hospital of Cecil County Elkton, MD
Medical groups
- Christiana Care Health Services Inc (1,483 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 508
- Services billed
- 971
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 110 | 106 |
| Ultrasonic guidance for blood vessel access | 103 | 97 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 90 | 90 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 50 | 50 |
| Established patient office or other outpatient visit, 20-29 minutes | 43 | 39 |
| Ultrasound of both sides of head and neck blood flow | 39 | 39 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 37 | 36 |
| Drainage of fluid from abdominal cavity using imaging guidance | 27 | 20 |
| Review by radiologist of arm or leg artery image | 24 | 24 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 20 | 18 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Newark, DE | 20 |
| Xarelto (rivaroxaban) Other prescribers in Newark, DE | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 16 companies reported 62 payments worth $24,102 in total to this clinician.
| Boston Scientific Corporation | $13,600 |
|---|---|
| Cagent Vascular Inc | $6,517 |
| Surmodics, Inc. | $2,234 |
| Vesalio, Inc. | $500 |
| Penumbra, Inc. | $468 |
| Balt USA, LLC | $265 |
| Thrombolex, Inc. | $141 |
| GE Healthcare | $87.53 |
| Consulting Fee | $20,600 |
|---|---|
| Food and Beverage | $2,642 |
| Travel and Lodging | $861 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Boston Scientific Corporation Sep 18, 2025 | Consulting Fee General - Therapies · General - Therapies_PI | $9,100 |
| Cagent Vascular Inc Oct 31, 2025 | Consulting Fee Serrantor · PNO | $2,000 |
| Cagent Vascular Inc May 28, 2025 | Consulting Fee Serrantor · PNO | $1,600 |
| Boston Scientific Corporation Sep 18, 2025 | Consulting Fee General - Therapies · General - Therapies_PI | $1,400 |
| Cagent Vascular Inc Apr 14, 2025 | Consulting Fee Serrantor · PNO | $1,200 |
| Cagent Vascular Inc Apr 14, 2025 | Consulting Fee Serrantor · PNO | $1,200 |
| Surmodics, Inc. May 29, 2025 | Consulting Fee Pounce Venous Thrombectomy System | $1,100 |
| Surmodics, Inc. Jul 9, 2025 | Consulting Fee Pounce Venous Thrombectomy System | $1,100 |
| Boston Scientific Corporation Sep 18, 2025 | Consulting Fee General - Therapies · General - Therapies_PI | $1,000 |
| Vesalio, Inc. Jul 29, 2025 | Consulting Fee | $500 |
All 14 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Cagent Vascular Inc Oct 31, 2025 | Consulting Fee Serrantor · PNO | $2,000 |
| Boston Scientific Corporation Sep 18, 2025 | Consulting Fee General - Therapies · General - Therapies_PI | $9,100 |
| Boston Scientific Corporation Sep 18, 2025 | Consulting Fee General - Therapies · General - Therapies_PI | $1,400 |
| Boston Scientific Corporation Sep 18, 2025 | Consulting Fee General - Therapies · General - Therapies_PI | $1,000 |
| Boston Scientific Corporation Sep 18, 2025 | Travel and Lodging General - Therapies · General - Therapies_PI · travel to Minneapolis, MN | $90.90 |
| Boston Scientific Corporation Aug 21, 2025 | Travel and Lodging JETSTREAM SC · JETSTREAM_PI · travel to Minneapolis, MN · in-kind | $426 |
| Boston Scientific Corporation Aug 21, 2025 | Travel and Lodging JETSTREAM SC · JETSTREAM_PI · travel to Minneapolis, MN · in-kind | $344 |
| Vesalio, Inc. Jul 29, 2025 | Consulting Fee | $500 |
| Surmodics, Inc. Jul 9, 2025 | Consulting Fee Pounce Venous Thrombectomy System | $1,100 |
| Surmodics, Inc. May 29, 2025 | Consulting Fee Pounce Venous Thrombectomy System | $1,100 |
| Cagent Vascular Inc May 28, 2025 | Consulting Fee Serrantor · PNO | $1,600 |
| Cagent Vascular Inc May 28, 2025 | Consulting Fee Serrantor · PNO | $400 |
| Cagent Vascular Inc Apr 14, 2025 | Consulting Fee Serrantor · PNO | $1,200 |
| Cagent Vascular Inc Apr 14, 2025 | Consulting Fee Serrantor · PNO | $1,200 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 2 companies. The companies reported $85,128 in research payments for these studies, mostly to the institutions running them.
- STRIKE-PE
Penumbra, Inc. - STRIDE II
Penumbra, Inc. - Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism
Boston Scientific Corporation · Active, not recruiting · NCT04790370 - Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
Boston Scientific Corporation · Recruiting · NCT04674969
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.